This team also designed a non-pathogenic strain of E. coli that specifically lyses within tumors and releases CD47 monoclonal antibodies, enhancing the activation of tumor-infiltrating T cells and improving the survival of tumor-bearing mice (Chowdhury et al., 2019). This evidence concerns the gene CD47 and neoplasm.